National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
Cardiovascular and Metabolic Disorder Programme, Duke-NUS Medical School, Singapore.
Curr Med Chem. 2018;25(11):1275-1293. doi: 10.2174/0929867324666170329100619.
The inflammatory response to acute myocardial ischaemia/ reperfusion injury (IRI) plays a critical role in determining myocardial infarct (MI) size, and subsequent post-MI left ventricular (LV) remodelling, making it a potential therapeutic target for improving clinical outcomes in patients presenting with an acute myocardial infarction (AMI). Recent experimental studies using advanced imaging and molecular techniques, have yielded new insights into the mechanisms through which reactive oxygen species (ROS) contribute to the inflammatory response induced by acute myocardial IRI - "adding fuel to the fire". The infiltration of inflammatory cells into the MI zone, leads to elevated myocardial concentrations of ROS, cytokine release, and activation of apoptotic and necrotic death pathways. Anti-oxidant and anti-inflammatory therapies have failed to protect the heart against acute myocardial IRI. This may be, in part, due to a lack of understanding of the time course, nature and mechanisms of the inflammation and redox dysregulation, which occur in the setting of acute myocardial IRI.
In this article, we examine the inflammatory response and redox dysregulation induced by acute myocardial IRI, and highlight potential therapeutic options for targeting redox dysregulation, in order to attenuate the detrimental effects of the inflammatory response following an AMI, so as to reduce MI size and prevent heart failure.
急性心肌缺血/再灌注损伤(IRI)的炎症反应在确定心肌梗死(MI)面积以及随后的 MI 后左心室(LV)重构方面起着关键作用,使其成为改善急性心肌梗死(AMI)患者临床结局的潜在治疗靶点。最近使用先进的成像和分子技术的实验研究,深入了解了活性氧(ROS)在急性心肌 IRI 诱导的炎症反应中的作用机制——“火上浇油”。炎症细胞浸润到 MI 区,导致 ROS、细胞因子释放和凋亡及坏死死亡途径的激活,使心肌浓度升高。抗氧化和抗炎治疗未能防止心脏免受急性心肌 IRI 的损伤。这可能部分归因于对急性心肌 IRI 时发生的炎症和氧化还原失调的时间进程、性质和机制缺乏了解。
本文检查了急性心肌 IRI 诱导的炎症反应和氧化还原失调,并强调了针对氧化还原失调的潜在治疗选择,以减轻 AMI 后炎症反应的有害影响,从而减小 MI 面积并预防心力衰竭。